カテゴリー： 世界, 医療/バイオ, LP Information

世界の抗アレルギー薬市場予測 2023年-2029年

【英語タイトル】Global Anti Allergy Medicine Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC07128）・商品コード：LP23DC07128
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：110
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の抗アレルギー薬市場」は、過去の販売実績から2022年の世界の抗アレルギー薬の総販売量を検討し、2023年から2029年の予測される抗アレルギー薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の抗アレルギー薬の市場規模を掲載し、XXX百万米ドル規模の世界の抗アレルギー薬市場の詳細な分析を提供します。本インサイトレポートは、世界の抗アレルギー薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の抗アレルギー薬市場における各社の独自のポジションをより深く理解するために、抗アレルギー薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の抗アレルギー薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。抗アレルギー薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。抗アレルギー薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。抗アレルギー薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

抗アレルギー薬の世界主要メーカーとしては、Johnson & Johnson、 Bayer Corp、 Sanofi、 Weefsel Pharma、 Arlak Biotech、 Hetero Healthcare、 Pharma Franchise、 Nutra Respiro、 Aden Healthcare、 Stallergenes Greer、 GSK、 Hikma Pharmaceuticals、 Med Globe Therapeutics Limited、 Taiho Pharmaceutical、 Regeneron Pharmaceuticals、 Glenmarkなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の抗アレルギー薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では抗アレルギー薬市場をセグメンテーションし、種類別 (抗ヒスタミン剤、アナフィラキシーメディエーター阻害剤、カルシウム剤、免疫抑制剤)、用途別 (オンライン薬局、病院、オフライン薬局、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：抗ヒスタミン剤、アナフィラキシーメディエーター阻害剤、カルシウム剤、免疫抑制剤

・用途別区分：オンライン薬局、病院、オフライン薬局、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の抗アレルギー薬市場の10年間の市場状況・展望は？
・世界および地域別に見た抗アレルギー薬市場成長の要因は何か？
・抗アレルギー薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・抗アレルギー薬のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：抗アレルギー薬の年間販売量2018-2029、地域別現状・将来分析
・抗アレルギー薬の種類別セグメント：抗ヒスタミン剤、アナフィラキシーメディエーター阻害剤、カルシウム剤、免疫抑制剤
・抗アレルギー薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・抗アレルギー薬の用途別セグメント：オンライン薬局、病院、オフライン薬局、診療所、その他
・抗アレルギー薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の抗アレルギー薬市場
・企業別のグローバル抗アレルギー薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別の抗アレルギー薬の年間売上：2018-2023年の売上、市場シェア
・企業別の抗アレルギー薬販売価格
・主要企業の抗アレルギー薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

抗アレルギー薬の地域別レビュー
・地域別の抗アレルギー薬市場規模2018-2023：年間販売量、売上
・主要国別の抗アレルギー薬市場規模2018-2023：年間販売量、売上
・南北アメリカの抗アレルギー薬販売の成長
・アジア太平洋の抗アレルギー薬販売の成長
・ヨーロッパの抗アレルギー薬販売の成長
・中東・アフリカの抗アレルギー薬販売の成長

南北アメリカ市場
・南北アメリカの国別の抗アレルギー薬販売量、売上（2018-2023）
・南北アメリカの抗アレルギー薬の種類別販売量
・南北アメリカの抗アレルギー薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の抗アレルギー薬販売量、売上（2018-2023）
・アジア太平洋の抗アレルギー薬の種類別販売量
・アジア太平洋の抗アレルギー薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の抗アレルギー薬販売量、売上（2018-2023）
・ヨーロッパの抗アレルギー薬の種類別販売量
・ヨーロッパの抗アレルギー薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の抗アレルギー薬販売量、売上（2018-2023）
・中東・アフリカの抗アレルギー薬の種類別販売量
・中東・アフリカの抗アレルギー薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・抗アレルギー薬の製造コスト構造分析
・抗アレルギー薬の製造プロセス分析
・抗アレルギー薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・抗アレルギー薬の主要なグローバル販売業者
・抗アレルギー薬の主要なグローバル顧客

地域別の抗アレルギー薬市場予測レビュー
・地域別の抗アレルギー薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・抗アレルギー薬の種類別市場規模予測
・抗アレルギー薬の用途別市場規模予測

主要企業分析
Johnson & Johnson、 Bayer Corp、 Sanofi、 Weefsel Pharma、 Arlak Biotech、 Hetero Healthcare、 Pharma Franchise、 Nutra Respiro、 Aden Healthcare、 Stallergenes Greer、 GSK、 Hikma Pharmaceuticals、 Med Globe Therapeutics Limited、 Taiho Pharmaceutical、 Regeneron Pharmaceuticals、 Glenmark
・企業情報
・抗アレルギー薬製品
・抗アレルギー薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Anti Allergy Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Anti Allergy Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Anti Allergy Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Anti Allergy Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Anti Allergy Medicine players cover Johnson & Johnson, Bayer Corp, Sanofi, Weefsel Pharma, Arlak Biotech, Hetero Healthcare, Pharma Franchise, Nutra Respiro and Aden Healthcare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Anti Allergy Medicine Industry Forecast” looks at past sales and reviews total world Anti Allergy Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti Allergy Medicine sales for 2023 through 2029. With Anti Allergy Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti Allergy Medicine industry.
This Insight Report provides a comprehensive analysis of the global Anti Allergy Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti Allergy Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti Allergy Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti Allergy Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti Allergy Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti Allergy Medicine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Antihistamines
Anaphylaxis Mediator Blocker Drugs
Calcium Drugs
Immunosuppressant Drugs
Segmentation by application
Online Pharmacy
Hospital
Offline Pharmacy
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Johnson & Johnson
Bayer Corp
Sanofi
Weefsel Pharma
Arlak Biotech
Hetero Healthcare
Pharma Franchise
Nutra Respiro
Aden Healthcare
Stallergenes Greer
GSK
Hikma Pharmaceuticals
Med Globe Therapeutics Limited
Taiho Pharmaceutical
Regeneron Pharmaceuticals
Glenmark
Key Questions Addressed in this Report
What is the 10-year outlook for the global Anti Allergy Medicine market?
What factors are driving Anti Allergy Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti Allergy Medicine market opportunities vary by end market size?
How does Anti Allergy Medicine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti Allergy Medicine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Anti Allergy Medicine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Anti Allergy Medicine by Country/Region, 2018, 2022 & 2029
2.2 Anti Allergy Medicine Segment by Type
2.2.1 Antihistamines
2.2.2 Anaphylaxis Mediator Blocker Drugs
2.2.3 Calcium Drugs
2.2.4 Immunosuppressant Drugs
2.3 Anti Allergy Medicine Sales by Type
2.3.1 Global Anti Allergy Medicine Sales Market Share by Type (2018-2023)
2.3.2 Global Anti Allergy Medicine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Anti Allergy Medicine Sale Price by Type (2018-2023)
2.4 Anti Allergy Medicine Segment by Application
2.4.1 Online Pharmacy
2.4.2 Hospital
2.4.3 Offline Pharmacy
2.4.4 Clinic
2.4.5 Others
2.5 Anti Allergy Medicine Sales by Application
2.5.1 Global Anti Allergy Medicine Sale Market Share by Application (2018-2023)
2.5.2 Global Anti Allergy Medicine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Anti Allergy Medicine Sale Price by Application (2018-2023)
3 Global Anti Allergy Medicine by Company
3.1 Global Anti Allergy Medicine Breakdown Data by Company
3.1.1 Global Anti Allergy Medicine Annual Sales by Company (2018-2023)
3.1.2 Global Anti Allergy Medicine Sales Market Share by Company (2018-2023)
3.2 Global Anti Allergy Medicine Annual Revenue by Company (2018-2023)
3.2.1 Global Anti Allergy Medicine Revenue by Company (2018-2023)
3.2.2 Global Anti Allergy Medicine Revenue Market Share by Company (2018-2023)
3.3 Global Anti Allergy Medicine Sale Price by Company
3.4 Key Manufacturers Anti Allergy Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti Allergy Medicine Product Location Distribution
3.4.2 Players Anti Allergy Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anti Allergy Medicine by Geographic Region
4.1 World Historic Anti Allergy Medicine Market Size by Geographic Region (2018-2023)
4.1.1 Global Anti Allergy Medicine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Anti Allergy Medicine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Anti Allergy Medicine Market Size by Country/Region (2018-2023)
4.2.1 Global Anti Allergy Medicine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Anti Allergy Medicine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Anti Allergy Medicine Sales Growth
4.4 APAC Anti Allergy Medicine Sales Growth
4.5 Europe Anti Allergy Medicine Sales Growth
4.6 Middle East & Africa Anti Allergy Medicine Sales Growth
5 Americas
5.1 Americas Anti Allergy Medicine Sales by Country
5.1.1 Americas Anti Allergy Medicine Sales by Country (2018-2023)
5.1.2 Americas Anti Allergy Medicine Revenue by Country (2018-2023)
5.2 Americas Anti Allergy Medicine Sales by Type
5.3 Americas Anti Allergy Medicine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti Allergy Medicine Sales by Region
6.1.1 APAC Anti Allergy Medicine Sales by Region (2018-2023)
6.1.2 APAC Anti Allergy Medicine Revenue by Region (2018-2023)
6.2 APAC Anti Allergy Medicine Sales by Type
6.3 APAC Anti Allergy Medicine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anti Allergy Medicine by Country
7.1.1 Europe Anti Allergy Medicine Sales by Country (2018-2023)
7.1.2 Europe Anti Allergy Medicine Revenue by Country (2018-2023)
7.2 Europe Anti Allergy Medicine Sales by Type
7.3 Europe Anti Allergy Medicine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti Allergy Medicine by Country
8.1.1 Middle East & Africa Anti Allergy Medicine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Anti Allergy Medicine Revenue by Country (2018-2023)
8.2 Middle East & Africa Anti Allergy Medicine Sales by Type
8.3 Middle East & Africa Anti Allergy Medicine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti Allergy Medicine
10.3 Manufacturing Process Analysis of Anti Allergy Medicine
10.4 Industry Chain Structure of Anti Allergy Medicine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti Allergy Medicine Distributors
11.3 Anti Allergy Medicine Customer
12 World Forecast Review for Anti Allergy Medicine by Geographic Region
12.1 Global Anti Allergy Medicine Market Size Forecast by Region
12.1.1 Global Anti Allergy Medicine Forecast by Region (2024-2029)
12.1.2 Global Anti Allergy Medicine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti Allergy Medicine Forecast by Type
12.7 Global Anti Allergy Medicine Forecast by Application
13 Key Players Analysis
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Anti Allergy Medicine Product Portfolios and Specifications
13.1.3 Johnson & Johnson Anti Allergy Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Bayer Corp
13.2.1 Bayer Corp Company Information
13.2.2 Bayer Corp Anti Allergy Medicine Product Portfolios and Specifications
13.2.3 Bayer Corp Anti Allergy Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bayer Corp Main Business Overview
13.2.5 Bayer Corp Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Anti Allergy Medicine Product Portfolios and Specifications
13.3.3 Sanofi Anti Allergy Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Weefsel Pharma
13.4.1 Weefsel Pharma Company Information
13.4.2 Weefsel Pharma Anti Allergy Medicine Product Portfolios and Specifications
13.4.3 Weefsel Pharma Anti Allergy Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Weefsel Pharma Main Business Overview
13.4.5 Weefsel Pharma Latest Developments
13.5 Arlak Biotech
13.5.1 Arlak Biotech Company Information
13.5.2 Arlak Biotech Anti Allergy Medicine Product Portfolios and Specifications
13.5.3 Arlak Biotech Anti Allergy Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Arlak Biotech Main Business Overview
13.5.5 Arlak Biotech Latest Developments
13.6 Hetero Healthcare
13.6.1 Hetero Healthcare Company Information
13.6.2 Hetero Healthcare Anti Allergy Medicine Product Portfolios and Specifications
13.6.3 Hetero Healthcare Anti Allergy Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Hetero Healthcare Main Business Overview
13.6.5 Hetero Healthcare Latest Developments
13.7 Pharma Franchise
13.7.1 Pharma Franchise Company Information
13.7.2 Pharma Franchise Anti Allergy Medicine Product Portfolios and Specifications
13.7.3 Pharma Franchise Anti Allergy Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Pharma Franchise Main Business Overview
13.7.5 Pharma Franchise Latest Developments
13.8 Nutra Respiro
13.8.1 Nutra Respiro Company Information
13.8.2 Nutra Respiro Anti Allergy Medicine Product Portfolios and Specifications
13.8.3 Nutra Respiro Anti Allergy Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Nutra Respiro Main Business Overview
13.8.5 Nutra Respiro Latest Developments
13.9 Aden Healthcare
13.9.1 Aden Healthcare Company Information
13.9.2 Aden Healthcare Anti Allergy Medicine Product Portfolios and Specifications
13.9.3 Aden Healthcare Anti Allergy Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Aden Healthcare Main Business Overview
13.9.5 Aden Healthcare Latest Developments
13.10 Stallergenes Greer
13.10.1 Stallergenes Greer Company Information
13.10.2 Stallergenes Greer Anti Allergy Medicine Product Portfolios and Specifications
13.10.3 Stallergenes Greer Anti Allergy Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Stallergenes Greer Main Business Overview
13.10.5 Stallergenes Greer Latest Developments
13.11 GSK
13.11.1 GSK Company Information
13.11.2 GSK Anti Allergy Medicine Product Portfolios and Specifications
13.11.3 GSK Anti Allergy Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 GSK Main Business Overview
13.11.5 GSK Latest Developments
13.12 Hikma Pharmaceuticals
13.12.1 Hikma Pharmaceuticals Company Information
13.12.2 Hikma Pharmaceuticals Anti Allergy Medicine Product Portfolios and Specifications
13.12.3 Hikma Pharmaceuticals Anti Allergy Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Hikma Pharmaceuticals Main Business Overview
13.12.5 Hikma Pharmaceuticals Latest Developments
13.13 Med Globe Therapeutics Limited
13.13.1 Med Globe Therapeutics Limited Company Information
13.13.2 Med Globe Therapeutics Limited Anti Allergy Medicine Product Portfolios and Specifications
13.13.3 Med Globe Therapeutics Limited Anti Allergy Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Med Globe Therapeutics Limited Main Business Overview
13.13.5 Med Globe Therapeutics Limited Latest Developments
13.14 Taiho Pharmaceutical
13.14.1 Taiho Pharmaceutical Company Information
13.14.2 Taiho Pharmaceutical Anti Allergy Medicine Product Portfolios and Specifications
13.14.3 Taiho Pharmaceutical Anti Allergy Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Taiho Pharmaceutical Main Business Overview
13.14.5 Taiho Pharmaceutical Latest Developments
13.15 Regeneron Pharmaceuticals
13.15.1 Regeneron Pharmaceuticals Company Information
13.15.2 Regeneron Pharmaceuticals Anti Allergy Medicine Product Portfolios and Specifications
13.15.3 Regeneron Pharmaceuticals Anti Allergy Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Regeneron Pharmaceuticals Main Business Overview
13.15.5 Regeneron Pharmaceuticals Latest Developments
13.16 Glenmark
13.16.1 Glenmark Company Information
13.16.2 Glenmark Anti Allergy Medicine Product Portfolios and Specifications
13.16.3 Glenmark Anti Allergy Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Glenmark Main Business Overview
13.16.5 Glenmark Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Anti Allergy Medicine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Anti Allergy Medicine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Antihistamines
Table 4. Major Players of Anaphylaxis Mediator Blocker Drugs
Table 5. Major Players of Calcium Drugs
Table 6. Major Players of Immunosuppressant Drugs
Table 7. Global Anti Allergy Medicine Sales by Type (2018-2023) & (K Units)
Table 8. Global Anti Allergy Medicine Sales Market Share by Type (2018-2023)
Table 9. Global Anti Allergy Medicine Revenue by Type (2018-2023) & ($ million)
Table 10. Global Anti Allergy Medicine Revenue Market Share by Type (2018-2023)
Table 11. Global Anti Allergy Medicine Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Anti Allergy Medicine Sales by Application (2018-2023) & (K Units)
Table 13. Global Anti Allergy Medicine Sales Market Share by Application (2018-2023)
Table 14. Global Anti Allergy Medicine Revenue by Application (2018-2023)
Table 15. Global Anti Allergy Medicine Revenue Market Share by Application (2018-2023)
Table 16. Global Anti Allergy Medicine Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Anti Allergy Medicine Sales by Company (2018-2023) & (K Units)
Table 18. Global Anti Allergy Medicine Sales Market Share by Company (2018-2023)
Table 19. Global Anti Allergy Medicine Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Anti Allergy Medicine Revenue Market Share by Company (2018-2023)
Table 21. Global Anti Allergy Medicine Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Anti Allergy Medicine Producing Area Distribution and Sales Area
Table 23. Players Anti Allergy Medicine Products Offered
Table 24. Anti Allergy Medicine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Anti Allergy Medicine Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Anti Allergy Medicine Sales Market Share Geographic Region (2018-2023)
Table 29. Global Anti Allergy Medicine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Anti Allergy Medicine Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Anti Allergy Medicine Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Anti Allergy Medicine Sales Market Share by Country/Region (2018-2023)
Table 33. Global Anti Allergy Medicine Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Anti Allergy Medicine Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Anti Allergy Medicine Sales by Country (2018-2023) & (K Units)
Table 36. Americas Anti Allergy Medicine Sales Market Share by Country (2018-2023)
Table 37. Americas Anti Allergy Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Anti Allergy Medicine Revenue Market Share by Country (2018-2023)
Table 39. Americas Anti Allergy Medicine Sales by Type (2018-2023) & (K Units)
Table 40. Americas Anti Allergy Medicine Sales by Application (2018-2023) & (K Units)
Table 41. APAC Anti Allergy Medicine Sales by Region (2018-2023) & (K Units)
Table 42. APAC Anti Allergy Medicine Sales Market Share by Region (2018-2023)
Table 43. APAC Anti Allergy Medicine Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Anti Allergy Medicine Revenue Market Share by Region (2018-2023)
Table 45. APAC Anti Allergy Medicine Sales by Type (2018-2023) & (K Units)
Table 46. APAC Anti Allergy Medicine Sales by Application (2018-2023) & (K Units)
Table 47. Europe Anti Allergy Medicine Sales by Country (2018-2023) & (K Units)
Table 48. Europe Anti Allergy Medicine Sales Market Share by Country (2018-2023)
Table 49. Europe Anti Allergy Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Anti Allergy Medicine Revenue Market Share by Country (2018-2023)
Table 51. Europe Anti Allergy Medicine Sales by Type (2018-2023) & (K Units)
Table 52. Europe Anti Allergy Medicine Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Anti Allergy Medicine Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Anti Allergy Medicine Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Anti Allergy Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Anti Allergy Medicine Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Anti Allergy Medicine Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Anti Allergy Medicine Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Anti Allergy Medicine
Table 60. Key Market Challenges & Risks of Anti Allergy Medicine
Table 61. Key Industry Trends of Anti Allergy Medicine
Table 62. Anti Allergy Medicine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Anti Allergy Medicine Distributors List
Table 65. Anti Allergy Medicine Customer List
Table 66. Global Anti Allergy Medicine Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Anti Allergy Medicine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Anti Allergy Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Anti Allergy Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Anti Allergy Medicine Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Anti Allergy Medicine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Anti Allergy Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Anti Allergy Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Anti Allergy Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Anti Allergy Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Anti Allergy Medicine Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Anti Allergy Medicine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Anti Allergy Medicine Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Anti Allergy Medicine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Johnson & Johnson Basic Information, Anti Allergy Medicine Manufacturing Base, Sales Area and Its Competitors
Table 81. Johnson & Johnson Anti Allergy Medicine Product Portfolios and Specifications
Table 82. Johnson & Johnson Anti Allergy Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Johnson & Johnson Main Business
Table 84. Johnson & Johnson Latest Developments
Table 85. Bayer Corp Basic Information, Anti Allergy Medicine Manufacturing Base, Sales Area and Its Competitors
Table 86. Bayer Corp Anti Allergy Medicine Product Portfolios and Specifications
Table 87. Bayer Corp Anti Allergy Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Bayer Corp Main Business
Table 89. Bayer Corp Latest Developments
Table 90. Sanofi Basic Information, Anti Allergy Medicine Manufacturing Base, Sales Area and Its Competitors
Table 91. Sanofi Anti Allergy Medicine Product Portfolios and Specifications
Table 92. Sanofi Anti Allergy Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Sanofi Main Business
Table 94. Sanofi Latest Developments
Table 95. Weefsel Pharma Basic Information, Anti Allergy Medicine Manufacturing Base, Sales Area and Its Competitors
Table 96. Weefsel Pharma Anti Allergy Medicine Product Portfolios and Specifications
Table 97. Weefsel Pharma Anti Allergy Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Weefsel Pharma Main Business
Table 99. Weefsel Pharma Latest Developments
Table 100. Arlak Biotech Basic Information, Anti Allergy Medicine Manufacturing Base, Sales Area and Its Competitors
Table 101. Arlak Biotech Anti Allergy Medicine Product Portfolios and Specifications
Table 102. Arlak Biotech Anti Allergy Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Arlak Biotech Main Business
Table 104. Arlak Biotech Latest Developments
Table 105. Hetero Healthcare Basic Information, Anti Allergy Medicine Manufacturing Base, Sales Area and Its Competitors
Table 106. Hetero Healthcare Anti Allergy Medicine Product Portfolios and Specifications
Table 107. Hetero Healthcare Anti Allergy Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Hetero Healthcare Main Business
Table 109. Hetero Healthcare Latest Developments
Table 110. Pharma Franchise Basic Information, Anti Allergy Medicine Manufacturing Base, Sales Area and Its Competitors
Table 111. Pharma Franchise Anti Allergy Medicine Product Portfolios and Specifications
Table 112. Pharma Franchise Anti Allergy Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Pharma Franchise Main Business
Table 114. Pharma Franchise Latest Developments
Table 115. Nutra Respiro Basic Information, Anti Allergy Medicine Manufacturing Base, Sales Area and Its Competitors
Table 116. Nutra Respiro Anti Allergy Medicine Product Portfolios and Specifications
Table 117. Nutra Respiro Anti Allergy Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Nutra Respiro Main Business
Table 119. Nutra Respiro Latest Developments
Table 120. Aden Healthcare Basic Information, Anti Allergy Medicine Manufacturing Base, Sales Area and Its Competitors
Table 121. Aden Healthcare Anti Allergy Medicine Product Portfolios and Specifications
Table 122. Aden Healthcare Anti Allergy Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Aden Healthcare Main Business
Table 124. Aden Healthcare Latest Developments
Table 125. Stallergenes Greer Basic Information, Anti Allergy Medicine Manufacturing Base, Sales Area and Its Competitors
Table 126. Stallergenes Greer Anti Allergy Medicine Product Portfolios and Specifications
Table 127. Stallergenes Greer Anti Allergy Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Stallergenes Greer Main Business
Table 129. Stallergenes Greer Latest Developments
Table 130. GSK Basic Information, Anti Allergy Medicine Manufacturing Base, Sales Area and Its Competitors
Table 131. GSK Anti Allergy Medicine Product Portfolios and Specifications
Table 132. GSK Anti Allergy Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. GSK Main Business
Table 134. GSK Latest Developments
Table 135. Hikma Pharmaceuticals Basic Information, Anti Allergy Medicine Manufacturing Base, Sales Area and Its Competitors
Table 136. Hikma Pharmaceuticals Anti Allergy Medicine Product Portfolios and Specifications
Table 137. Hikma Pharmaceuticals Anti Allergy Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Hikma Pharmaceuticals Main Business
Table 139. Hikma Pharmaceuticals Latest Developments
Table 140. Med Globe Therapeutics Limited Basic Information, Anti Allergy Medicine Manufacturing Base, Sales Area and Its Competitors
Table 141. Med Globe Therapeutics Limited Anti Allergy Medicine Product Portfolios and Specifications
Table 142. Med Globe Therapeutics Limited Anti Allergy Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Med Globe Therapeutics Limited Main Business
Table 144. Med Globe Therapeutics Limited Latest Developments
Table 145. Taiho Pharmaceutical Basic Information, Anti Allergy Medicine Manufacturing Base, Sales Area and Its Competitors
Table 146. Taiho Pharmaceutical Anti Allergy Medicine Product Portfolios and Specifications
Table 147. Taiho Pharmaceutical Anti Allergy Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Taiho Pharmaceutical Main Business
Table 149. Taiho Pharmaceutical Latest Developments
Table 150. Regeneron Pharmaceuticals Basic Information, Anti Allergy Medicine Manufacturing Base, Sales Area and Its Competitors
Table 151. Regeneron Pharmaceuticals Anti Allergy Medicine Product Portfolios and Specifications
Table 152. Regeneron Pharmaceuticals Anti Allergy Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Regeneron Pharmaceuticals Main Business
Table 154. Regeneron Pharmaceuticals Latest Developments
Table 155. Glenmark Basic Information, Anti Allergy Medicine Manufacturing Base, Sales Area and Its Competitors
Table 156. Glenmark Anti Allergy Medicine Product Portfolios and Specifications
Table 157. Glenmark Anti Allergy Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Glenmark Main Business
Table 159. Glenmark Latest Developments
List of Figures
Figure 1. Picture of Anti Allergy Medicine
Figure 2. Anti Allergy Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti Allergy Medicine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Anti Allergy Medicine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Anti Allergy Medicine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Antihistamines
Figure 10. Product Picture of Anaphylaxis Mediator Blocker Drugs
Figure 11. Product Picture of Calcium Drugs
Figure 12. Product Picture of Immunosuppressant Drugs
Figure 13. Global Anti Allergy Medicine Sales Market Share by Type in 2022
Figure 14. Global Anti Allergy Medicine Revenue Market Share by Type (2018-2023)
Figure 15. Anti Allergy Medicine Consumed in Online Pharmacy
Figure 16. Global Anti Allergy Medicine Market: Online Pharmacy (2018-2023) & (K Units)
Figure 17. Anti Allergy Medicine Consumed in Hospital
Figure 18. Global Anti Allergy Medicine Market: Hospital (2018-2023) & (K Units)
Figure 19. Anti Allergy Medicine Consumed in Offline Pharmacy
Figure 20. Global Anti Allergy Medicine Market: Offline Pharmacy (2018-2023) & (K Units)
Figure 21. Anti Allergy Medicine Consumed in Clinic
Figure 22. Global Anti Allergy Medicine Market: Clinic (2018-2023) & (K Units)
Figure 23. Anti Allergy Medicine Consumed in Others
Figure 24. Global Anti Allergy Medicine Market: Others (2018-2023) & (K Units)
Figure 25. Global Anti Allergy Medicine Sales Market Share by Application (2022)
Figure 26. Global Anti Allergy Medicine Revenue Market Share by Application in 2022
Figure 27. Anti Allergy Medicine Sales Market by Company in 2022 (K Units)
Figure 28. Global Anti Allergy Medicine Sales Market Share by Company in 2022
Figure 29. Anti Allergy Medicine Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Anti Allergy Medicine Revenue Market Share by Company in 2022
Figure 31. Global Anti Allergy Medicine Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Anti Allergy Medicine Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Anti Allergy Medicine Sales 2018-2023 (K Units)
Figure 34. Americas Anti Allergy Medicine Revenue 2018-2023 ($ Millions)
Figure 35. APAC Anti Allergy Medicine Sales 2018-2023 (K Units)
Figure 36. APAC Anti Allergy Medicine Revenue 2018-2023 ($ Millions)
Figure 37. Europe Anti Allergy Medicine Sales 2018-2023 (K Units)
Figure 38. Europe Anti Allergy Medicine Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Anti Allergy Medicine Sales 2018-2023 (K Units)
Figure 40. Middle East & Africa Anti Allergy Medicine Revenue 2018-2023 ($ Millions)
Figure 41. Americas Anti Allergy Medicine Sales Market Share by Country in 2022
Figure 42. Americas Anti Allergy Medicine Revenue Market Share by Country in 2022
Figure 43. Americas Anti Allergy Medicine Sales Market Share by Type (2018-2023)
Figure 44. Americas Anti Allergy Medicine Sales Market Share by Application (2018-2023)
Figure 45. United States Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Anti Allergy Medicine Sales Market Share by Region in 2022
Figure 50. APAC Anti Allergy Medicine Revenue Market Share by Regions in 2022
Figure 51. APAC Anti Allergy Medicine Sales Market Share by Type (2018-2023)
Figure 52. APAC Anti Allergy Medicine Sales Market Share by Application (2018-2023)
Figure 53. China Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Anti Allergy Medicine Sales Market Share by Country in 2022
Figure 61. Europe Anti Allergy Medicine Revenue Market Share by Country in 2022
Figure 62. Europe Anti Allergy Medicine Sales Market Share by Type (2018-2023)
Figure 63. Europe Anti Allergy Medicine Sales Market Share by Application (2018-2023)
Figure 64. Germany Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Anti Allergy Medicine Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Anti Allergy Medicine Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Anti Allergy Medicine Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Anti Allergy Medicine Sales Market Share by Application (2018-2023)
Figure 73. Egypt Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Anti Allergy Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Anti Allergy Medicine in 2022
Figure 79. Manufacturing Process Analysis of Anti Allergy Medicine
Figure 80. Industry Chain Structure of Anti Allergy Medicine
Figure 81. Channels of Distribution
Figure 82. Global Anti Allergy Medicine Sales Market Forecast by Region (2024-2029)
Figure 83. Global Anti Allergy Medicine Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Anti Allergy Medicine Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Anti Allergy Medicine Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Anti Allergy Medicine Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Anti Allergy Medicine Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の抗アレルギー薬市場予測 2023年-2029年] (コード：LP23DC07128)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の抗アレルギー薬市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の熱中症対策医薬品市場予測 2023年-2029年
  • 世界の花粉アレルギー用注射市場予測 2023年-2029年
  • 世界の季節性アレルギー治療市場予測 2023年-2029年
  • 世界のアンチエイジング漢方薬市場予測 2023年-2029年
  • 世界の抗呼吸器合胞体ウイルス薬市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆